Referenties

  1. Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79(1):39-52.
  2. LCI.RIVM handleiding vaccinatie bij hematologische aandoeningen [Available from: https://lci.rivm.nl/richtlijnen/vaccinatie-bij-hematologische-aandoeningen]
  3. Syed-Ahmed M, Narayanan M. Immune Dysfunction and Risk of Infection in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2019;26(1):8-15.
  4. Richtlijn vaccinatie pre-niertransplantatie voor volwassenen [Available from: https://www.transplantatievereniging.nl/richtlijnen-en-protocollen].
  5. Mulley WR, Dendle C, Ling JEH, Knight SR. Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis. J Heart Lung Transplant. 2018;37(7):844-52.
  6. Chong PP, Handler L, Weber DJ. A Systematic Review of Safety and Immunogenicity of Influenza Vaccination Strategies in Solid Organ Transplant Recipients. Clin Infect Dis. 2018;66(11):1802-11.
  7. Trunk AD, Shewan SK, Lee CJ, Parker CJ, Couriel DR. Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination. Bone Marrow Transplant. 2022;57(3):502-3.
  8. Huber F, Ehrensperger B, Hatz C, Chappuis F, Buhler S, Eperon G. Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss Travel Clinics. J Travel Med. 2018;25(1).
  9. Miauton A, Tan R, Pantazou V, Du Pasquier R, Genton B. Vaccine-associated measles in a patient treated with natalizumab: a case report. BMC Infect Dis. 2020;20(1):753.
  10. Berger JR. Varicella vaccination after fingolimod: A case report. Mult Scler Relat Disord. 2013;2(4):391-4.
  11. HIGHLIGHTS OF PRESCRIBING INFORMATION Entyvio.
  12. LCR protocol Hepatitis A [Available from: https://mijnlcr.nl/].
  13. LCI.RIVM richtlijn hepatitis B [Available from: https://lci.rivm.nl/richtlijnen/hepatitis-b#index_Risicogroepen].
  14. FMS richtlijn Primaire preventie van waterpokken [Available from: https://richtlijnendatabase.nl/richtlijn/varicella/primaire_preventie_van_waterpokken.html].
  15. LCI.RIVM richtlijn waterpokken [Available from: https://lci.rivm.nl/richtlijnen/waterpokken-en-gordelroos].
  16. Kaneko T, Ishigatsubo Y. Varicella pneumonia in adults. Intern Med. 2004;43(12):1105-6.
  17. LCR protocol stollingsstoornissen [Available from: https://mijnlcr.nl/].
  18. LCI.RIVM uitvoeringsrichtlijn Covid-19 vaccinatie [Available from: https://lci.rivm.nl/richtlijnen/covid-19-vaccinatie].
  19. FMS richtlijn Tuberculose en HIV.  [Available from Startpagina – Tuberculose en HIV – Richtlijn – Richtlijnendatabase]
  20. Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis. 2021;15(6):879-913.
  21. European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-98.
  22. LCI.RIVM richtlijn Mazelen [Available from: https://lci.rivm.nl/richtlijnen/mazelen].
  23. LCR protocol Bof Mazelen en Rode hond (BMR) [Available from: www.mijnlcr.nl].
  24. Guideline for the prevention and treatment of opportunistic infections in adults and adolescents with HIV.
  25. Mejia R, Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis. 2012;25(4):458-63.
  26. Carnino L, Schwob JM, Getaz L, Nickel B, Neumayr A, Eperon G. A Practical Approach to Screening for Strongyloides stercoralis. Trop Med Infect Dis. 2021;6(4).
  27. LCI.RIVM handleiding Vaccinatie bij chronisch inflammatoire aandoeningen [Available from: https://lci.rivm.nl/richtlijnen/vaccinatie-bij-chronisch-inflammatoire-aandoeningen].
  28. LCI.RIVM richtlijn HPV-vaccinatie [Available from: https://lci.rivm.nl/richtlijnen/hpv-vaccinatie].
  29. L’Huillier AG, Hirzel C, Ferreira VH, Ierullo M, Ku T, Selzner N, et al. Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients. Transplantation. 2021;105(10):2316-23.
  30. LCR protocol indicaties contra-indicaties interferentie [Available from: https://mijnlcr.nl/]
  31. LCR protocol Gele koorts [Available from: http://mijnlcr.nl/]
  32. Peter Vink, Josep Maria Ramon Torrell, Ana Sanchez Fructuoso, Sung-Joo Kim, Sang-II Kim, Jeff Zaltzman et al. Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A phase 3, Randomized Clinical Trial. 2020 Jan 2;70(2):181-190.
  33. LCI.RIVM handleiding Covid-19-vaccinatie van immuungecompromitteerde patiënten [Available from: https://lci.rivm.nl/handleiding-covid-19-vaccinatie-van-immuungecompromitteerde-patienten] 
  34. Imke Redeker, Katinka Albrecht, Joern Kekow, Gerd Rüdiger Burmester, Juergen Braun, Martin Schäfer, et al. Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register. Ann Rheum Dis. 2022 Jan;81(1):41-47. 
  35. Pablo A Olivera, Juan S Lasa, Stefanos Bonovas, Silvio Danese, Laurent Peyrin-Biroulet. Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis. Gastroenterology. 2020 May; 158(6):1554-1573.e12.
  36. Kevin L Winthrop, Hisashi Yamanaka, Hernan Valdez, Eric Mortensen, Robert Chew, Sriram Krishnaswami, et al. Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014 Oct;66(10):2675-84.
  37. Vincenzo Venerito, Pasquale Stefanizzi, Luca Cantarini, Marlea Lavista, Maria Grazia Galeone, Antonio Di Lorenzo, et al. Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study. Int J Mol Sci. 2023 Apr 9;24(8):6967. 
  38. Cintia Muñoz-Quiles, Mónica López-Lacort, Javier Díez-Domingo, Alejandro Orrico-Sánchez. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009-2014. BMC Infect Dis. 2020 Nov 30;20(1):905.
  39. Barbara P Yawn, Peter C Wollan, Marge J Kurland, Jennifer L St Sauver, Patricia Saddier. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011 Feb;86(2):88-93.

  40. Colin J Forsyth, Jennifer Manne-Goehler , Caryn Bern, Jeffrey Whitman, Natasha S Hochberg, Morven Edwards, et al. Recommendations for Screening and Diagnosis of Chagas Disease in the United States. J Infect Dis. 2022 May 4;225(9):1601-1610.

  41. NVHB nationale HIV behandelrichtlijn. [Available from: Inhoud – Richtlijnen HIV (nvhb.nl)].

Website ontwikkeld door aim